- CEO
- Neil David Crabb
- Full Time Employees
- 14
- Sector
- Commercial services
- Industry
- Miscellaneous commercial services
- Address
- 78 Cannon Street Edinburgh SC United Kingdom EC4N 6AF
- IPO Date
- Jan 31, 2011
- Business
- Frontier IP Group Plc Frontier IP Group Plc specializes in the commercialization of intellectual property derived from universities, academics, and research institutions across the UK, Portugal, and Italy. The company provides advisory services, hands-on commercialization support, technology validation, early industry engagement, and fundraising assistance to spin-out companies; its portfolio spans clusters including artificial intelligence, innovative materials, enabling health, food and agritech, energy, and water technologies, with key portfolio companies such as Cambridge Raman Imaging (graphene-enhanced lasers for imaging), Dekiln (BioSintering for low-carbon ceramic tiles), 2D Photonics (high-speed data solutions), Pulsiv Solar (photovoltaic efficiency enhancements), Alusid (recycled materials mimicking stone), The Vaccine Group (veterinary vaccines), and Amprologix (novel antibiotics). Frontier IP Group Plc maintains operations primarily in the UK with extensions to Europe, targets research institutions and early-stage technology ventures, and is headquartered in London with 21 employees.
Founded in 2007 and listed on the AIM market of the London Stock Exchange, the company takes equity stakes in spin-outs in exchange for commercialization services rather than cash, aiming to scale technologies toward market exits.
In recent developments, Frontier IP Group Plc entered a strategic partnership in June 2025 with Abstract Mid-Tech Limited to establish an innovation hub in Cambridge, set to open by year-end, enhancing deal flow, portfolio scaling, investor access, and operational efficiency for UK, Italian, and Portuguese companies; portfolio progress includes The Vaccine Group's successful bovine respiratory syncytial virus vaccine trials and Amprologix's fundraising for antibiotic development, alongside Alusid's international distribution agreement.